AU2002336148A1 - Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine - Google Patents
Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccineInfo
- Publication number
- AU2002336148A1 AU2002336148A1 AU2002336148A AU2002336148A AU2002336148A1 AU 2002336148 A1 AU2002336148 A1 AU 2002336148A1 AU 2002336148 A AU2002336148 A AU 2002336148A AU 2002336148 A AU2002336148 A AU 2002336148A AU 2002336148 A1 AU2002336148 A1 AU 2002336148A1
- Authority
- AU
- Australia
- Prior art keywords
- rsv
- vaccine
- protein
- respiratory syncytial
- syncytial virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000725643 Respiratory syncytial virus Species 0.000 title 2
- 108091006011 G proteins Proteins 0.000 title 1
- 102000030007 GTP-Binding Proteins Human genes 0.000 title 1
- 108091000058 GTP-Binding Proteins Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccines Drugs 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR01/09731 | 2001-07-20 | ||
| FR0109731A FR2827605B1 (en) | 2001-07-20 | 2001-07-20 | NOVEL PEPTIDES DERIVED FROM RSV PROTEIN G AND THEIR USE IN A VACCINE |
| PCT/FR2002/002599 WO2003010317A1 (en) | 2001-07-20 | 2002-07-19 | Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| AU2002336148A1 true AU2002336148A1 (en) | 2003-05-29 |
| AU2002336148B2 AU2002336148B2 (en) | 2007-12-13 |
| AU2002336148B8 AU2002336148B8 (en) | 2008-06-19 |
Family
ID=8865750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002336148A Ceased AU2002336148B8 (en) | 2001-07-20 | 2002-07-19 | Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7309494B2 (en) |
| EP (1) | EP1409692B1 (en) |
| JP (1) | JP4310184B2 (en) |
| CN (1) | CN1556857A (en) |
| AT (1) | ATE408696T1 (en) |
| AU (1) | AU2002336148B8 (en) |
| BR (1) | BR0211296A (en) |
| CA (1) | CA2455360A1 (en) |
| DE (1) | DE60228971D1 (en) |
| DK (1) | DK1409692T3 (en) |
| ES (1) | ES2314102T3 (en) |
| FR (1) | FR2827605B1 (en) |
| MX (1) | MXPA04000597A (en) |
| PT (1) | PT1409692E (en) |
| WO (1) | WO2003010317A1 (en) |
| ZA (1) | ZA200400916B (en) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1334119B2 (en) | 2000-10-18 | 2018-11-28 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Compositions and methods for modulating rsv infection and immunity |
| WO2006023029A2 (en) * | 2004-06-16 | 2006-03-02 | The Johns Hopkins University | The cysteine-rich region of respiratory syncytial virus and methods of use therefor |
| EP1972348A1 (en) * | 2007-03-14 | 2008-09-24 | Pierre Fabre Medicament | Novel vaccine composition for the treatment of respiratory infectious diseases |
| NZ591768A (en) | 2008-09-18 | 2012-11-30 | Novartis Ag | Vaccine adjuvant combinations |
| WO2011017442A2 (en) * | 2009-08-04 | 2011-02-10 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Anti-rsv immunogens and methods of immunization |
| CA2772103A1 (en) | 2009-08-27 | 2011-03-03 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
| ES2443952T3 (en) | 2009-09-02 | 2014-02-21 | Novartis Ag | Immunogenic compositions that include modulators of TLR activity |
| CA2784970A1 (en) | 2009-12-21 | 2011-07-14 | Cornell University | Novel pneumovirus compositions and methods for using the same |
| EP2719395A1 (en) | 2010-09-01 | 2014-04-16 | Novartis AG | Adsorption of immunopotentiators to insoluble metal salts |
| WO2012082914A1 (en) | 2010-12-14 | 2012-06-21 | Novartis Ag | Flow cytometry analysis of materials adsorbed to metal salts |
| JP6191082B2 (en) | 2011-03-02 | 2017-09-06 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Combination vaccine with lower dose of antigen and / or adjuvant |
| KR20140027211A (en) | 2011-04-04 | 2014-03-06 | 유니버시티 오브 아이오와 리써치 파운데이션 | Methods of improving vaccine immunogenicity |
| ES2395677B1 (en) * | 2011-07-29 | 2013-12-26 | Instituto De Salud Carlos Iii | VRSH F protein in stabilized pre-fusion conformation and specific neutralizing antibodies against it. |
| CN103239734B (en) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | For preventing and/or treating the vaccine of respiratory syncytial virus infection |
| US20150132339A1 (en) | 2012-03-07 | 2015-05-14 | Novartis Ag | Adjuvanted formulations of streptococcus pneumoniae antigens |
| CA2865759C (en) | 2012-03-07 | 2020-07-21 | Novartis Ag | Immunologically useful arginine salts |
| RU2014140521A (en) | 2012-03-08 | 2016-04-27 | Новартис Аг | ADJUVANT COMPOSITIONS OF BOOSTER VACCINES |
| CN109266622B (en) | 2012-08-01 | 2023-05-09 | 巴法里安诺迪克有限公司 | Recombinant modified vaccinia virus ankara (MVA) Respiratory Syncytial Virus (RSV) vaccine |
| CN105085684B (en) * | 2014-05-14 | 2020-04-17 | 上海亨臻实业有限公司 | Design and application of PCSK9 targeted recombinant vaccine |
| WO2016160166A1 (en) | 2015-03-30 | 2016-10-06 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Immunogenic rsv polypeptides |
| BR112018016648A2 (en) | 2016-02-16 | 2018-12-26 | The University Of Queensland | alpha-conotoxin peptides |
| CN109232737A (en) * | 2016-03-01 | 2019-01-18 | 苏州博泰神州生物技术有限公司 | A kind of full human monoclonal antibody for RSV attachment G protein surface antigen |
| JP7253034B2 (en) | 2019-02-28 | 2023-04-05 | Ｋｍバイオロジクス株式会社 | RSV F/G chimeric vaccine |
| US11360877B2 (en) * | 2020-09-14 | 2022-06-14 | International Business Machines Corporation | Forming microservices from monolithic applications |
| WO2024084785A1 (en) * | 2022-10-20 | 2024-04-25 | 一般財団法人阪大微生物病研究会 | Composition suitable for use as rs virus vaccine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3689622T2 (en) | 1986-01-14 | 1994-06-16 | Univ North Carolina | Vaccines against human respiratory viruses. |
| US5223254A (en) * | 1987-09-29 | 1993-06-29 | Praxis Biologics, Inc. | Respiratory syncytial virus: vaccines |
| FR2718452B1 (en) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Element of immunogen, immunogenic agent, pharmaceutical composition and method of preparation. |
| AUPO026596A0 (en) | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
| FR2766192B1 (en) | 1997-07-17 | 2001-07-13 | Pf Medicament | EPITOPES OF RSV AND ANTIBODIES COMPRISING SAME, USEFUL IN DIAGNOSIS AND THERAPY |
| FR2776521B1 (en) | 1998-03-27 | 2000-12-15 | Pf Medicament | USE OF P40 ACTIVE CONJUGATES BY NASAL |
| FR2798857B1 (en) * | 1999-09-23 | 2003-06-06 | Pf Medicament | USE OF AN OMPA MEMBRANE PROTEIN OF ENTEROBACTERIA ASSOCIATED WITH AN RSV IMMUNOGENIC PEPTIDE FOR THE PREPARATION OF NASAL ADMINISTRATIVE VACCINES |
-
2001
- 2001-07-20 FR FR0109731A patent/FR2827605B1/en not_active Expired - Fee Related
-
2002
- 2002-07-19 DE DE60228971T patent/DE60228971D1/en not_active Expired - Fee Related
- 2002-07-19 DK DK02770043T patent/DK1409692T3/en active
- 2002-07-19 JP JP2003515667A patent/JP4310184B2/en not_active Expired - Fee Related
- 2002-07-19 ES ES02770043T patent/ES2314102T3/en not_active Expired - Lifetime
- 2002-07-19 CA CA002455360A patent/CA2455360A1/en not_active Abandoned
- 2002-07-19 PT PT02770043T patent/PT1409692E/en unknown
- 2002-07-19 AT AT02770043T patent/ATE408696T1/en not_active IP Right Cessation
- 2002-07-19 CN CNA028184475A patent/CN1556857A/en active Pending
- 2002-07-19 MX MXPA04000597A patent/MXPA04000597A/en active IP Right Grant
- 2002-07-19 US US10/484,298 patent/US7309494B2/en not_active Expired - Fee Related
- 2002-07-19 EP EP02770043A patent/EP1409692B1/en not_active Expired - Lifetime
- 2002-07-19 WO PCT/FR2002/002599 patent/WO2003010317A1/en active IP Right Grant
- 2002-07-19 AU AU2002336148A patent/AU2002336148B8/en not_active Ceased
- 2002-07-19 BR BR0211296-5A patent/BR0211296A/en not_active IP Right Cessation
-
2004
- 2004-02-04 ZA ZA200400916A patent/ZA200400916B/en unknown
-
2007
- 2007-11-16 US US11/985,839 patent/US7524627B2/en not_active Expired - Fee Related
-
2009
- 2009-03-02 US US12/380,671 patent/US20090181042A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002336148A1 (en) | Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine | |
| GB0211558D0 (en) | Anti-inflammatory and immunomodulatory amino acid derivatives,their preparation and use | |
| AU2002234643A1 (en) | Amphoteric liposomes and the use thereof | |
| AU2002255952A1 (en) | Short bioactive peptides and methods for their use | |
| EP1462455A4 (en) | Novel peptides and medicinal uses thereof | |
| AU2002233457A1 (en) | Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine | |
| EP1425039A4 (en) | Human papilloma virus immunoreative peptides | |
| EP1414848A4 (en) | Replikin peptides and uses thereof | |
| EP1419175A4 (en) | Replikin peptides and uses thereof | |
| AU2002343462A1 (en) | Recombinant respiratory syncytial viruses with deleted surface glycoprotein genes and uses thereof | |
| AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
| AU2001278337A1 (en) | Respiratory syncytial virus vaccine | |
| AU2003242222A1 (en) | A recombinant anti-enveloped virus peptide and its preparation | |
| AU2003231980A1 (en) | Identification of apoptotic peptides and methods of use thereof | |
| AU2002312373A1 (en) | Structural and cytoskeleton-associated proteins | |
| AU2002230129A1 (en) | Novel physiologically active peptide and use thereof | |
| AU2002343042A8 (en) | Virulence proteins of the genus yersinia and uses thereof | |
| AU2002338856A1 (en) | Peptides derived from the superantigen (sag) env protein of herv-k18 and their use in obtaining sag-inhibitory antibodies and in vaccination against sag | |
| AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
| EP1406921A4 (en) | Hypoglycaemic peptides and methods of use thereof | |
| AU2001248750A1 (en) | Novel physiologically active peptides and use thereof | |
| AU2002354188B2 (en) | Novel peptides and medicinal uses thereof | |
| AUPR589701A0 (en) | Novel peptide and use thereof | |
| AU2003240866A1 (en) | Antibodies, peptides and vaccines against hiv-1 virus | |
| AU2002343516A1 (en) | Structural and cytoskeleton-associated proteins |